Condition category
Nutritional, Metabolic, Endocrine
Date applied
Date assigned
Last edited
Retrospectively registered
Overall trial status
Recruitment status
No longer recruiting
Publication status

Plain English Summary

Background and study aims
People living with diabetes often have to live with long-term complications of the disease. One of these complications is diabetic peripheral neuropathy, where nerve damage is caused in the arms, hands, legs and feet. People suffering from diabetic peripheral neuropathy are at much greater risk of developing problems with their feet, such as foot ulcers, because the damage to the nerves reduces sensation in the foot. It is thought that high pressure on the heel and bottom of the foot (plantar pressure) increases the risk of diabetic foot ulcers. For this reason, people with diabetic neuropathy are often prescribed custom-made insoles in order to reduce the pressure on the parts of the foot that usually develop ulcers. The aim of this study is to compare insoles that have been designed using a computer simulation to those designed using traditional methods, in order to find the best design for helping relieve the pressure foot pressure for diabetic patients.

Who can participate?
Diabetic adults with diabetic peripheral neuropathy in the foot and elevated planar pressures

What does the study involve?
Each participant is provided with three sets of insoles to use. The first is a standard insole which is made using traditional methods and is the standard insole currently prescribed. The second insole is designed using a computer simulation and is made using a mold. The third insole is also designed using a computer simulation and is made using 3D printing. The two insoles made using a computer simulation are tailor-made for each participants’ feet so that the best support possible is given. The participants are asked to wear each of the insoles for approximately 5 minutes, and are asked to walk at least 20 steps. A number of sensors are placed between the foot and the insole within their shoes, which measures the plantar pressure to find how each insole is relieving this pressure.

What are the possible benefits and risks of participating?
A benefit of participating in this study is that an experienced podiatrist will carry out a foot exam. If any problems are found, then a doctor will be notified so that treatment can be arranged. Also, participants can keep the three sets of personalised insoles made for them in the study. There are no potential risks of participating.

Where is the study run from?
University Hospital Ayr (UK)

When is the study starting and how long is it expected to run for?
March 2015 to October 2015

Who is funding the study?
Seventh Framework Programme (Belgium)

Who is the main contact?
Dr Scott Telfer

Trial website

Contact information



Primary contact

Dr Scott Telfer


Contact details

Institute of Applied Health Research
Glasgow Caledonian University
Cowcaddens Road
G4 0BA
United Kingdom
+44 (0)141 331 8475

Additional identifiers

EudraCT number number

Protocol/serial number


Study information

Scientific title

Optimisation of custom insoles for pressure relief in patients with diabetes via finite element modelling


Study hypothesis

Custom insoles optimised using computer simulations of forefoot loading will provide significantly better forefoot offloading at sites of elevated pressure than those designed using standard techniques.

Ethics approval

West of Scotland Research Ethics Committee 4, 27/01/2015, ref: 14/WS/1150

Study design

Single-centre randomised repeated measures crossover design

Primary study design


Secondary study design

Randomised cross over trial

Trial setting


Trial type


Patient information sheet

Not available in web format, please use the contact details to request a patient information sheet


Diabetes with peripheral neurpathy


Three interventions are administered to each participant in a randomised, crossover fashion:
1. Standard, total contact insole with modifications for forefoot offloading (control). This is a traditionally designed insole that is currently the standard device prescribed for at risk diabetic feet.
2. Virtually optimised pressure offloading insole manufactured through direct milling. This is an insole design that has been optimised for pressure offloading using a numerical model simulation and is manufactured via direct milling.
3. Virtually optimised pressure offloading insole manufactured through 3D printing. This is an insole design that has been optimised for pressure offloading using a numerical model simulation and is manufactured via 3D printing.
The study tests the acute effects of the insoles. Each participant will have approximately 5 minutes to acclimatise to each pair of insoles before being data collection. The in-shoe measurement system is a flexible array of sensors that is placed between the foot and the insole and records interface forces. We will collect at least 20 steps of data for each foot.

Intervention type



Drug names

Primary outcome measure

Forefoot peak plantar pressure, measured using an in-shoe plantar pressure measurement system (Pedar, Novel GmbH, Munich) at a single timepoint immediately after the insoles are provided to the patient

Secondary outcome measures

Validation of computational models in this patient population comparing the predicted plantar pressures to those measured experimentally

Overall trial start date


Overall trial end date


Reason abandoned (if study stopped)


Participant inclusion criteria

1. 18-75 years of age
2. Shoe size 5-11 (UK)
3. Able to walk 300m (including ~20m barefoot) safely
4. Diabetes mellitus Type 1 or 2 with duration ≥10 years
5. Diabetic peripheral neuropathy defined as loss of sensation to 10g monofilament test at one or more forefoot sites
6. Elevated barefoot plantar pressure (>700kPa) measured at the forefoot during walking

Participant type


Age group




Target number of participants


Participant exclusion criteria

1. Lower limb, foot or digital amputation (at a level proximal to the distal IPJ, or involving the hallux)
2. Severe callus (callus will not result in exclusion if it has been reduced to a level that does not affect sensation of underlying skin)
3. History of medical conditions, injuries or surgical procedures that significantly influence gait, or which cause pain on walking (including Charcot)
4. Severe foot deformity or reduction in ROM that result in abnormal gait or preclude good fit of study shoe (including Charcot)
5. Severe concurrent medical condition that would prevent participation in study procedures (e.g. severe cardiac/pulmonary condition that precludes activity) or with life expectancy ≤ 3 months.
6. Pregnancy

Recruitment start date


Recruitment end date



Countries of recruitment

United Kingdom

Trial participating centre

University Hospital Ayr
Dalmellington Road
United Kingdom

Sponsor information


Glasgow Caledonian University

Sponsor details

Cowcaddens Road
G4 0BA
United Kingdom

Sponsor type




Funder type


Funder name

Seventh Framework Programme

Alternative name(s)

EC Seventh Framework Programme, European Commission Seventh Framework Programme, EU Seventh Framework Programme, European Union Seventh Framework Programme, FP7

Funding Body Type

government organisation

Funding Body Subtype

National government


Results and Publications

Publication and dissemination plan

We intend to publish two papers from this study:
1. Reporting the performance of the different insole conditions for forefoot pressure offloading
2. Reporting the performance of the computational simulations predictions for the performance of the insoles compared to the experimentally measured data

Intention to publish date


Participant level data

Available on request

Basic results (scientific)

Publication list

2017 results in:

Publication citations

Additional files

Editorial Notes

10/07/2017: Publication reference added.